openPR Logo
Press release

Drug-Device Combination Products Market to 2023 (6.9% CAGR Expected) Top Player Profiles – Abbott Laboratories, Medtronic Plc, Smith & Nephew Plc, Boston Scientific Corporation, GlaxoSmithKline plc, Becton, Dickinson and Company, Johnson & Johnson and M

09-21-2018 08:44 PM CET | Health & Medicine

Press release from: Research Beam

Drug-Device Combination Products

Drug-Device Combination Products

Drug-Device Combination Products Market by Product (Drug-eluting Stent, Infusion Pump, Photodynamic Therapy, Antimicrobial Wound Dressing, Prefilled Syringe, Drug-eluting Balloon, Nebulizer, Inhaler, Transdermal Delivery System, and Others), Application (Cardiovascular Treatment, Diabetes, Respiratory Problem, Cancer Treatment, Antimicrobial Application, and Others), and End User (Hospital & Clinic, Ambulatory Surgical Center, Home Care Setting, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2025

Drug-device combination products comprise of two or more regulated components, which work in coordination. These components involve a medical device, which is used to administer a therapeutic drug in the patient's body. The drug-device combination products can be single products comprising of several components or products packed separately, intended for use with a specialized counterpart. The therapeutic drugs used along with the specific device are either mixed physically or chemically to obtain a resulting mixture for the final use. Currently, the best-known example of drug-device combination product is the drug-eluting stents that are scaffolds coated with a therapeutic drug to prevent growth of tissue scars in an artery.

Get Sample Copy of this Report @ https://www.researchbeam.com/drug-device-combination-products-market/request-sample?utm_source=Anil&utm_medium=OPR

The global drug-device combination products market was valued at $81,374 million in 2017 and is projected to reach $139,193 million by 2025 at a CAGR of 6.9% from 2018 to 2025. Increase in prevalence of chronic diseases such as diabetes, cardiovascular disorders, respiratory problems, and cancer, drive the growth of the global drug-device combination products market. Further, rise in geriatric population, technological advancements in drug-device combination product, and surge in homebased healthcare market are the other factors that boost the market growth. However, stringent governmental regulations for the approval of combination devices and post-complications and errors lead to numerous product recalls that hinder the growth of the global market. On the contrary, rise in healthcare infrastructure and high market potential in untapped emerging economies are anticipated to serve as lucrative opportunities for market expansion.

Top Manufacturers: Abbott Laboratories, Medtronic Plc, Smith & Nephew Plc, Boston Scientific Corporation, GlaxoSmithKline plc, Becton, Dickinson and Company, Johnson & Johnson, Novartis AG, Bayer AG, Baxter International, Inc.

The global drug-device combination products market is segmented based on product, application, end user, and region. Based on product, the market is segmented into drug-eluting stent, infusion pump, photodynamic therapy, antimicrobial wound dressing, prefilled syringe, drug-eluting balloon, nebulizer, inhaler, transdermal delivery system, and other products. Drug-eluting stents are further sub-segmented into coronary drug-eluting stent and peripheral drug-eluting stent. The infusion pumps segment is further divided into implantable infusion pumps, insulin infusion pumps, patient-controlled analgesia pumps, and ambulatory infusion pumps. Similarly, prefilled syringes are further categorized into single-chamber prefilled syringes, dual-chamber prefilled syringes, and customized prefilled syringes. The drug-eluting balloons segment is bifurcated into coronary drug-eluting balloons and peripheral drug-eluting balloons. The inhalers segment is further segmented into drug powder inhalers (DPIs), metered dose inhalers (MDIs), and soft mist inhalers (SMIs). Lastly, transdermal delivery systems segment is divided into passive delivery systems and active delivery systems.

As per application, the market is categorized into cardiovascular diseases, diabetes, respiratory problems, cancer treatment, antimicrobial applications, and other applications. Considering the end-user segment, the market is segregated into hospital & clinic, ambulatory surgery center, home care setting, and other end users. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the global drug-device combination products market with current trends and future estimations from 2017 to 2025 to elucidate the imminent investment pockets.
A comprehensive analysis of factors that drive and restrict the market growth is provided.
Factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global & regional scale are provided.
Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the market.
Get a discount on this research report @ https://www.researchbeam.com/drug-device-combination-products-market/purchase-enquiry?utm_source=Anil&utm_medium=OPR

Key Market Segments

By Product

Drug-eluting stent
Infusion pump
Photodynamic therapy
Antimicrobial wound dressing
Prefilled syringe
Drug-eluting balloon
Nebulizer
Inhaler
Transdermal delivery system
Other products
By Application

Cardiovascular disease
Diabetes
Respiratory problem
Cancer treatment
Antimicrobial application
Other applications
By End user

Hospital & Clinic
Ambulatory Surgery Center (ASCs)
Home Care Setting
Other end users
Table of Content:

CHAPTER 1: INTRODUCTION

1.1. Report Description

1.2. Key Benefits for Stakeholders

1.3. Key Market Segments

1.3.1. List of key players profiled in the report

1.4. Research Methodology

1.4.1. Secondary research

1.4.2. Primary research

1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY

2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market Definition and Scope

3.2. Key findings

3.2.1. Top Winning Strategies

3.2.2. Top Investment Pockets

3.3. Top Player Positioning, 2017

3.4. Government Regulations

3.4.1. U.S. FDA

3.4.2. Europe CE Mark

3.4.3. Ministry of Health, Labor, and Welfare (MHLW)

3.4.4. Central Drug Standards Control Organization (CDSCO)

3.5. Market Dynamics

3.5.1. Drivers

3.5.1.1. Rapidly aging population and favorable demographics worldwide

3.5.1.2. Rise in incidence of chronic conditions

3.5.1.3. Technological advancements in drug-device combination products

3.5.1.4. Growth in home-based healthcare market

3.5.2. Restraints

3.5.2.1. Stringent approval process of these products

3.5.2.2. Occurrence of several errors and number of product recalls

3.5.3. Opportunities

3.5.3.1. Opportunities in emerging markets

3.5.4. Impact Analyses

3.6. Patent Analysis (2013-2018)

3.6.1. Patent analysis, by year

3.6.2. Patent analysis, by country

Enquiry before Buy @ https://www.researchbeam.com/drug-device-combination-products-market/enquire-about-report?utm_source=Anil&utm_medium=OPR

About Us:

Research Beam is a high end and wide online market for market research reports that contain detailed and rational market research. Research Beam is a one stop report destination that offers clients well drafted and accurately analyzed report with insightful data.

Global Head Quarters
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
+1 (800) 910-6452
help@researchbeam.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug-Device Combination Products Market to 2023 (6.9% CAGR Expected) Top Player Profiles – Abbott Laboratories, Medtronic Plc, Smith & Nephew Plc, Boston Scientific Corporation, GlaxoSmithKline plc, Becton, Dickinson and Company, Johnson & Johnson and M here

News-ID: 1256053 • Views:

More Releases from Research Beam

Proton Therapy Market: Global Analysis & Forecast by Koninklijke Philips N.V., Advanced Oncotherapy, Varian Medical Systems, Inc., Optivus Proton Therapy, Inc., Hitachi and More
Proton Therapy Market: Global Analysis & Forecast by Koninklijke Philips N.V., A …
Market study on Global Proton Therapy Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023 Research Report presents a professional and complete analysis of Global Proton Therapy Market on the current market situation. This report focuses on the Proton Therapy in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Request
Artificial Lift System Market by Top Key Participant The major companies profiled in the report includes:GE Oil & Gas, National Oilwell Varco, Weatherford Plc, Halliburton, Dover Corp.
Artificial Lift System Market by Top Key Participant The major companies profile …
The market research report ‘Global Artificial Lift System, 2018 Market Research Report’ aims to offer insights into new business opportunities for companies active in Artificial Lift Systemas well as for those players that are aiming to get an entry into the industry. Artificial Lift System Market by Type (Rod lift, ESP, PCP, Plunger, Gas lift, Others), Component (Pump, Motor, Cable System, Drive head, Separator, Pump Jack, Sucker Rod, Gas-lift Valves,
Artificial Intelligence in Healthcare Market Report Competition by Manufacturers, Type & Application, Growth & Opportunities 2023
Artificial Intelligence in Healthcare Market Report Competition by Manufacturers …
Artificial Intelligence in Healthcare Market by Offering (Hardware, Software, and Services), Technology (Deep Learning, Querying Method, Natural Language Processing, and Context Aware Processing), Application (Robot-assisted Surgery, Virtual Nursing Assistant, Administrative Workflow Assistance, Fraud Detection, Dosage Error Reduction, Clinical Trial Participant Identifier, Preliminary Diagnosis, and Others), and End User (Healthcare Provider, Pharmaceutical & Biotechnology Company, Patient, and Payer) - Global Opportunity Analysis and Industry Forecast, 2017-2023 Request Sample copy of this Report
Artificial Turf Market Key Player Analysis By - Victoria PLC (Avalon Grass), Sportfield Deutschland Holding GmbH (AstroTurf), CoCreation Grass Corporation, FieldTurf
Artificial Turf Market Key Player Analysis By - Victoria PLC (Avalon Grass), Spo …
Artificial turfs are synthetic surfaces made of fibers including polyethylene, polypropylene, and polyamides. These are used across the globe due to attractive features such as high durability, low maintenance, superior quality, all weather utility, visual appeal, and eco-friendly attribute. Such turfs are in high demand in sports such as football, hockey, baseball, golf, and other activities that require a durable grass surface. Furthermore, these turfs can be 100% recycled due

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug